FASTKD2

Chr 2AR

FAST kinase domains 2

Also known as: COXPD44, KIAA0971

The protein is essential for assembly of the mitochondrial large ribosomal subunit and controls 16S mitochondrial ribosomal RNA abundance, which is required for intra-mitochondrial translation. Mutations cause combined oxidative phosphorylation deficiency 44, inherited in an autosomal recessive pattern. The gene is highly constrained against loss-of-function variants (LOEUF 0.75), reflecting its critical role in mitochondrial protein synthesis.

OMIMResearchSummary from RefSeq, OMIM, UniProt
MultiplemechanismARLOEUF 0.751 OMIM phenotype
Clinical SummaryFASTKD2
🧬
Gene-Disease Validity (ClinGen)
mitochondrial disease · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.75LOEUF
pLI 0.000
Z-score 2.60
OE 0.48 (0.320.75)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
0.67Z-score
OE missense 0.90 (0.820.99)
328 obs / 363.7 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.48 (0.320.75)
00.351.4
Missense OE0.90 (0.820.99)
00.61.4
Synonymous OE1.11
01.21.6
LoF obs/exp: 14 / 29.2Missense obs/exp: 328 / 363.7Syn Z: -0.97
DN
0.6647th %ile
GOF
0.6735th %ile
LOF
0.2582th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

FASTKD2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →